Category Archives: Indian Patent Law

Delhi HC upholds Roche’s patent claims on Tarceva against Cipla

Economic Times, November 28, 2015. Mumbai – A division bench of the Delhi High Court sided with Roche against Indian firm Cipla, upholding the Swiss drug maker’s patent claims on key lung cancer drug erlotinib hydrochloride, branded Tarceva. The ruling is … Continue reading

Posted in Cancer, Patent infringement, Sec 3 (d) | Leave a comment

Drug patenting in India: looking back and looking forward

Nature reviews. By Bhaven N. Sampat and Kenneth C. Shadlen. Patent protection for drugs in India has been a contentious issue in recent years, with several high-profile denials of patents — for example, for Novartis’ anticancer drug imatinib mesylate (Glivec; also … Continue reading

Posted in Indian Patent Law, Patents, Sec 3 (d) | Leave a comment

India – IPR Think Tank draft IP policy – MSF comments on access and innovation

The IPR Think Tank was convened in November 2014 by Department of Industrial Policy & Promotion (DIPP), Ministry of Commerce, Government of India, to draft a national IPR Policy for India.  Medécins Sans Frontières gives its views on the final version … Continue reading

Posted in Indian Patent Law, IPR policy, IPR Think Tank | 2 Comments

IPR policy to go for Cabinet Approval soon – Commerce Minister

NEW DELHI: In a reaction to the leak of the final draft of India’s new IPR policy on this blog and comments from spicy-ip, Commerce and Industry Minister Nirmala Sitharaman stated last Thursday that the leaked draft policy is not the final version , … Continue reading

Posted in Indian Patent Law, IPR Enforcement, IPR policy, IPR Think Tank | 1 Comment

Final draft, India National IPR Policy, by IP Think Tank constituted by DIPP, Ministry of Commerce and Industry

Comment by Knowledge Ecology International on India’s leaked IPR policy draft posted on this blog. October 14, 2015

Posted in Indian Patent Law, IP Rights, IPR Enforcement, IPR policy, IPR Think Tank, Transfer of Technology, TRIPS plus, US pressure on India | Leave a comment

Drugs row threatens health sector budget

Source: Daily Nation; October 6, 2015 Kenya may be forced to increase its future annual health budget, if global drug companies have their way in the simmering patents row surrounding the manufacture of medicines. They have pushed India, Kenya’s biggest … Continue reading

Posted in EU-India FTA, Indian Patent Law, Indian Patent Office, IP Rights, IPR policy, LDCs, Uncategorized | Leave a comment

India rejects patent on Pfizer’s arthritis drug

Source: Reuters 7 Sep 2015 India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.

Posted in Indian Patent Law | Leave a comment